MIT study reveals a new role for cell membranes
Peer-Reviewed Publication
Updates every hour. Last Updated: 22-Jun-2026 18:16 ET (22-Jun-2026 22:16 GMT/UTC)
MIT chemists have found that changing the composition of the cell membrane can alter the function of EGFR, a cell receptor that promotes proliferation and is often overactive in cancer cells.
The gut microbiota drives changes to the immune system caused by chronic sleep loss. These changes promote cancer progression, disrupt circadian rhythm and weaken the effectiveness of chemotherapy.
According to a study from MIT, NDMA, a carcinogen that has been found in some drugs and drinking water contaminated by chemical plants, may have a much more severe impact on children than adults.
New work demonstrates that editing just a handful of blood stem cells can permanently program the immune system to manufacture therapeutic proteins, which can be boosted through vaccination. This proof of concept, demonstrated in mice, shows that this strategy could one day enable durable treatments in humans for HIV, influenza, cancer, and metabolic disease.
A new review from the Icahn School of Medicine at Mount Sinai and the Hospital Clínic de Barcelona provides one of the clearest roadmaps to date for understanding and treating liver cancer, one of the deadliest cancers worldwide.